UK signs off on Sanofi, AstraZeneca's RSV antibody four days after Europe
First, it was the CHMP. Then the European Commission, and as of Wednesday, the UK’s MHRA (but still no FDA).
The UK’s Medicines and Healthcare …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
